Volume | 303 |
|
|||||
News | - | ||||||
Day High | 5.25 | Low High |
|||||
Day Low | 5.01 |
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
Regencell Bioscience Holdings Ltd | RGC | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
5.25 | 5.01 | 5.25 | 5.01 | 5.00 |
Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
---|---|---|---|---|---|
11 | 303 | US$ 5.01 | US$ 1,518 | - | 3.16 - 30.49 |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
15:00:00 | 1 | US$ 5.10 | USD |
Regencell Bioscience Holdings Ltd Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
65.19M | 13.01M | - | 0 | -5.87M | -0.45 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Regencell Bioscience News
Date | Time | Source | News Article |
---|---|---|---|
1/02/2024 | 05:04 | Edgar (US Regulatory) | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |
12/15/2023 | 05:09 | Edgar (US Regulatory) | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |
10/27/2023 | 15:15 | Edgar (US Regulatory) | Form 20-F - Annual and transition report of foreign private.. |
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical RGC Price Data
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 4.98 | 5.47 | 4.641 | 5.17 | 2,580 | 0.03 | 0.60% |
1 Month | 5.09 | 6.69 | 4.35 | 5.41 | 1,856 | -0.08 | -1.57% |
3 Months | 6.66 | 8.60 | 3.16 | 4.81 | 4,709 | -1.65 | -24.77% |
6 Months | 12.00 | 12.00 | 3.16 | 5.32 | 2,564 | -6.99 | -58.25% |
1 Year | 23.00 | 30.49 | 3.16 | 10.22 | 2,186 | -17.99 | -78.22% |
3 Years | 12.00 | 59.00 | 3.16 | 31.65 | 79,327 | -6.99 | -58.25% |
5 Years | 12.00 | 59.00 | 3.16 | 31.65 | 79,327 | -6.99 | -58.25% |
Regencell Bioscience Description
Regencell Bioscience Holdings Ltd is engaged in the research, development and commercialization of traditional chinese medicine. The medicines are used for the treatment of neurocognitive disorders and degeneration. |